Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Septic Shock
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Prospective, randomized, controlled, three-arm, open-label, international, multi-centre, phase III studyMasking: Single (Outcomes Assessor)Masking Description: No masking is applied in this study, as it is impossible to blind the medical personnel and participants. Statisticians will be blinded to allocationPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 80 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04742764
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Péter Hegyi, MD, PhD, DSc Insitute for Translational Medicine, University of Pécs, Medical School, Pécs, Hungary
Get Well Soon